MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 121 to 140 of 166,322 approvalsPage 7 of 8317

Ibuprofen Sustained-release Capsules

Approval Number: 国药准字H20254378
Registration: May 27, 2025

Levodopa and Benserazide Hydrochloride Tablets

Approval Number: 国药准字H20254391
Registration: May 27, 2025

Ceftazidime and Avibactam Sodium for Injection

Approval Number: 国药准字H20254290
Registration: May 27, 2025

Gliclazide Sustained-release Tablets

Approval Number: 国药准字H20254382
Registration: May 27, 2025

Dacomitinib Tablets

Approval Number: 国药准字H20254268
Registration: May 27, 2025

Dacomitinib Tablets

Approval Number: 国药准字H20254254
Registration: May 27, 2025

Formoterol fumarate Inhalation Solution

Approval Number: 国药准字H20254361
Registration: May 27, 2025

Fluvoxamine Maleate Tablets

Approval Number: 国药准字H20254294
Registration: May 27, 2025

Pediatric Compound Amino Acid Injection(19AA-Ⅰ-SF)

Approval Number: 国药准字H20254390
Registration: May 27, 2025

Epinephrine Hydrochloride Injection

Approval Number: 国药准字H20254338
Registration: May 27, 2025

Paracetamol and Ibuprofen Tablets

Approval Number: 国药准字H20254285
Registration: May 27, 2025

Avatrombopag Maleate tablet

Approval Number: 国药准字H20254261
Registration: May 27, 2025

Cytarabine for Injection

Approval Number: 国药准字H20254280
Registration: May 27, 2025

Phloroglucinol Injection

Approval Number: 国药准字H20254295
Registration: May 27, 2025

Drotaverine Hydrochloride Tablets

Approval Number: 国药准字H20254367
Registration: May 27, 2025

Levodopa and Benserazide Hydrochloride Tablets

Approval Number: 国药准字H20254379
Registration: May 27, 2025

Compound Sodium Acetate Ringer’s Injection

Approval Number: 国药准字H20254344
Registration: May 27, 2025

Tadalafil Tablets

Approval Number: 国药准字H20254296
Registration: May 27, 2025

Tadalafil Tablets

Approval Number: 国药准字H20254357
Registration: May 27, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.